Euroasian journal of hepato-gastroenterology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  13 (2023)
Volume  12 (2022)
Volume  11 (2021)
Volume  10 (2020)
Volume  9 (2019)
Volume  8 (2018)
Volume  7 (2017)
Volume  6 (2016)
Volume  5 (2015)
Volume  4 (2014)
Volume  3 (2013)
Volume  2 (2012)
Volume  1 (2011)
Related articles

VOLUME 6 , ISSUE 1 ( January-June, 2016 ) > List of Articles

MINI REVIEW

Viral Hepatitis in Mongolia: Past, Present, and Future

Bira Tsatsralt Od

Citation Information : Tsatsralt Od B. Viral Hepatitis in Mongolia: Past, Present, and Future. Euroasian J Hepatogastroenterol 2016; 6 (1):56-58.

DOI: 10.5005/jp-journals-10018-1168

License: CC BY-NC 4.0

Published Online: 01-07-2016

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

Viral hepatitis is one of the major health concerns worldwide, particularly in Asian countries. Mongolia, which is located in northern Asia, between Russia and China, is confronting various infectious diseases, such as viral hepatitis and tuberculosis. As for healthy individuals in Mongolia, the reported prevalence of hepatitis B surface antigen (HBsAg) was 9 or 10% and the reported prevalence of anti-hepatitis C virus ranged from 11 to 25%. We reported a markedly high prevalence of hepatitis D virus RNA (83%) among apparently healthy individuals with HBsAg in Ulaanbaatar. Also due to lack of proper mechanisms to handle sewerage, disinfection, and lack of clean water supply across the country, hepatitis A is endemic in Mongolia. Moreover, Mongolia ranked in the high-prevalence zone for hepatitis B, D, and C.

PDF Share
  1. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004 Dec;132(6):1005-1022
  2. Comparison of hepatitis A and E virus infections among healthy children in Mongolia: evidence for infection with a subgenotype IA HAV in children. J Med Virol 2007 Jan;79(1):18-25
  3. Prevalence of hepatitis B and C virus markers in outpatients of Mongolian general hospitals. Kansenshogaku Zasshi 1998 Jan;72(1):5-11
  4. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 2004 Mar;11(2):392-398
  5. Prevalence of hepatitis viruses in patients with acute hepatitis and characterization of the detected genotype 4 hepatitis E virus sequences in Mongolia. J Med Virol 2016 Feb;88(2):282-291
  6. Health Sector 2002: reducing maternal mortality. Ulaanbaatar (Mongolia): Ministry of Health of Mongolia; 2002
  7. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 2005 Dec;150(12):2513-2528
  8. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol 2005 Dec;77(4): 491-499.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.